BIO Deutschland Member Directory

Regensburg, Germany

2bind is a contract research organization in the field of biophysical analysis. The company's clients and collaborators mainly work in drug discovery (hit identification, hit validation, and hit characterization), aptamer generation, antibody development, and protein biochemistry. The company's mission is to support and help their partners with their innovative biophysical services to drive their science.

3B Pharmaceuticals GmbH

Berlin, Germany

3B Pharmaceuticals GmbH (3BP) is a biotechnology company developing targeted radiopharmaceutical drugs and diagnostics for oncology indications with a high unmet medical need. The company is active in peptide discovery and optimization and has built a technology platform extending from hit identification to early clinical development. Technologies are applied to both in-house and collaborative R&D.

4SC AG

Planegg-Martinsried, Germany

4SC AG is a clinical-stage biopharmaceutical company developing small-molecule drugs that can target key indications in cancer with high unmet medical needs through epigenetic mechanisms. The company's current product pipeline includes two programs in clinical development: resminostat and domatinostat.

AB Enzymes GmbH

Darmstadt, Germany

AB Enzymes develops and distributes enzymes. The products range from food enzymes for baking and beverages to enzymes for animal feed, textile technology and the detergents industry. AB Enzymes’ focus in the biofuel market is in the use of lignocellulosic biomass to produce transport fuels.

Abalos Therapeutics GmbH

Düsseldorf, Germany

Abalos Therapeutics develop a novel anti-cancer approach that provides the full breadth of the immune system’s power specifically against cancer cells. Abalos’ arenavirus-based drug candidates are designed to awake precise immune responses and activate all relevant immune cell types against primary tumors and metastases.

AbbVie Deutschland GmbH & Co. KG

Wiesbaden, Germany

AbbVie Deutschland GmbH & Co. KG is a global, research-based biopharmaceutical company. The company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases.

Acaryon GmbH

Schildow, Germany

Acaryon GmbH is a company specialized in the development of specific and innovative natural microorganisms for probiotic and microbiome applications for the pharmaceutical and food industry. Moreover, Acaryon provides analytical services for a different range of purposes.

acCELLerate GmbH

Hamburg, Germany

acCELLerate GmbH develops cell based assay kits for applications in research, safety, quality control and diagnostics. The company's instaCELL bioassays are based on ready made Frozen Instant Cells which can be directly used in an assay without prior cultivation or even cell counting. The kits contain all required components, assay plates, medium, reagents, controls and cells.

Acousia Therapeutics GmbH

Tübingen, Germany

Acousia Therapeutics GmbH is a privately held biotech company which identifies small molecules for the treatment of hearing loss. The company's therapeutic approach replaces lost sensory hair cells, the key cells for hearing in the inner ear, by cellular regeneration originating from supporting cells. In addition, this therapy also focuses on the treatment of age-related decrease in hearing capacity.

acromion GmbH

Frechen, Germany

acromion GmbH is an independent, privately-owned, full-service CRO. The company provides full-service in trial organization and conduct, clinical monitoring, clinical data management, statistics, quality assurance, and medical writing for phase I to IV clinical and non-interventional (NIS) studies.

Adrenomed AG

Hennigsdorf, Germany

Adrenomed AG is a German privately financed, clinical stage biopharmaceutical company. Adrenomed´s mission is to rescue vascular integrity in order to save the lives of critically ill patients with limited treatment options. The company’s lead product candidate Adrecizumab is a clinical-stage, first-in-class monoclonal antibody. Adrecizumab targets the vasoprotective peptide Adrenomedullin, an essential regulator of vascular integrity. Adrecizumab is currently under clinical evaluation in...

Aeterna Zentaris GmbH

Frankfurt, Germany

Aeterna Zentaris is a specialty biopharmaceutical company engaged in developing and commercializing novel treatments in oncology, endocrinology and women's health. The development and research site is based in Germany.

Affimed N.V

Heidelberg, Germany

Affimed GmbH is a clinical-stage biopharmaceutical company focused on discovering and developing cancer immunotherapies. The company's product candidates are developed in the field of innate immuno-oncology, which represents an approach to cancer research that seeks to harness the body's own immune system to fight tumor cells.

AGC Biologics – Heidelberg

Heidelberg, Germany

AGC Biologics is a global contract development and manufacturing organization (CDMO), dedicated to the development and manufacture of biopharmaceuticals, from pre-clinical to commercial. The company offers deep industry expertise and uniquely customized services for the scale-up and cGMP manufacture of protein-based therapeutics, from pre-clinical to commercial production, using mammalian and microbial production systems.

AiCuris Anti-infective Cures AG

Wuppertal, Germany

AiCuris Anti-infective Cures AG, a leading company in the discovery and development of drugs against infectious diseases, today announced the start of pivotal phase 3 development with its proprietary lead compound pritelivir, a novel helicase-primase inhibitor, following encouraging phase 2 interim results achieved in the phase 2 part of its clinical phase 2/3 trial, PRIOH-1. The PRIOH-1 multi-center open label trial is designed to evaluate the efficacy and safety of orally administered pritelivir...

AIT Austrian Institute of Technology GmbH

Vienna, Austria

AIT Austrian Institute of Technology GmbH is a non-university research institution and the Molecular Diagnostics business unit within the Health & Environment Department. AIT provides research and technological development to understand the basic innovations for the next generation of infrastructure related technologies in the fields of energy, mobility systems, low-emission transport, health & bioresources, digital safety & security, vision, automation & control and technology experience.

akampion

Berlin, Germany

akampion provides full-service public relations, investor relations and marketing communications to healthcare and technology companies. The company's services include Reputation management, strategic advice, integrated corporate communications, storytelling, public relations, investor relations, product PR, perception studies, marketing, online PR, media training and employee branding.

Alacris Theranostics GmbH

Berlin, Germany

Alacris Theranostics GmbH is a systems medicine company which is specialized in developing approaches for cancer precision medicine, biomarker discovery and drug development. The company provides next generation sequencing services for various applications, including DNA sequencing, such as whole genome and targeted sequencing; strand-specific RNA sequencing that includes RNA and mRNA sequencing; small RNA sequencing; and ChIP-Seq.

Algiax Pharmaceuticals GmbH

Erkrath, Germany

Algiax Pharmaceuticals GmbH is a clinical-stage biotechnology company. The company offers discovery and drug development in the field of central nervous systems (CNS) illnesses and dysfunctions, with a focus on neuropathic pain.

altona Diagnostics GmbH

Hamburg, Germany

altona Diagnostics develops and commercializes real-time PCR based assays and molecular diagnostic test solutions in the field of infectious diseases.